使用129Xe MRI与综合肺功能检查对哮喘和/或慢性阻塞性肺疾病进行表型分型
该研究从初级保健机构招募≥16岁、由医生诊断为哮喘和/或慢阻肺的患者,进行支气管舒张剂后的129Xe MRI、质子MRI、多次呼吸氮冲洗、空气波振荡法、TLco、体描记和肺量计检查。共评估165例患者,129Xe MRI和肺功能指标在诊断组间存在显著差异。慢阻肺患者较哮喘患者通气减低且更不均匀、腺泡尺寸增大、气体转移降低,肺量计更低、气道阻力与电抗更差、气体陷闭更多;仅在FEV1或TLco正常的患者中比较时,129Xe MRI指标仍显示慢阻肺比哮喘异常更重。哮喘+慢阻肺患者肺功能与结构比哮喘差、比慢阻肺好。结论认为129Xe MRI联合肺功能检查提供表型不同的气道疾病特征,有助于诊断,且对轻微肺病高度敏感,可能帮助指导治疗决策。
要点
- 在165例真实世界哮喘和/或慢阻肺患者中,129Xe MRI和肺功能指标在诊断组间差异显著。
- 慢阻肺患者较哮喘患者129Xe MRI通气减低且更不均匀、腺泡尺寸增大、气体转移降低。
- 慢阻肺患者较哮喘患者肺量计更低、气道阻力与电抗更差、气体陷闭更多。
- 仅在FEV1或TLco正常的患者中比较,129Xe MRI指标仍显示慢阻肺比哮喘异常更重。
- 哮喘+慢阻肺患者肺功能与结构比哮喘差、比慢阻肺好。
适用人群与场景
- ≥16岁、由医生诊断为哮喘和/或慢阻肺、从初级保健机构招募的患者。
研究设计与关键结果
- 研究评估165例患者,129Xe MRI和肺功能指标在诊断组间差异显著。
- 慢阻肺患者较哮喘患者129Xe MRI通气显著减低且更不均匀、腺泡尺寸增大、气体转移降低。
- 慢阻肺患者较哮喘患者肺量计更低、气道阻力与电抗更差、气体陷闭更多。
- 仅在FEV1或TLco正常的患者中比较,129Xe MRI指标仍显示慢阻肺比哮喘异常更重。
- 哮喘+慢阻肺患者肺功能与结构比哮喘差、比慢阻肺好。
证据类型、等级与局限
- 证据类型:研究论文(横断面研究,从初级保健招募患者)。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为129Xe MRI联合肺功能检查提供表型不同的气道疾病特征,有助于哮喘和/或慢阻肺的诊断。
- 作者认为129Xe MRI对轻微肺病高度敏感,识别出的功能/结构表型可能帮助指导治疗决策。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
RATIONALE: Asthma and chronic obstructive pulmonary disease (COPD) significantly overlap by conventional diagnostic criteria, yet important treatment differences remain, and people with both asthma and COPD (asthma + COPD) have worse clinical outcomes than people with a single diagnosis. Hyperpolarized xenon-129 magnetic resonance imaging (129Xe MRI) and pulmonary function tests (PFTs) are sensitive to lung function and structure.
OBJECTIVE: To determine whether 129Xe MRI alongside PFTs can aid phenotyping of real-world patients with asthma and/or COPD.
METHODS: Patients ≥16 years with physician-assigned asthma and/or COPD were recruited from primary care. 129Xe and proton MRI, multiple-breath nitrogen washout, airwave oscillometry, transfer factor of the lung for carbon monoxide (TLco), body plethysmography, and spirometry were assessed post-bronchodilator. Differences between diagnostic groups were assessed.
RESULTS: The study assessed 165 patients. 129Xe MRI and PFT metrics differed significantly between diagnostic groups. On 129Xe MRI, patients with COPD had significantly reduced and more heterogeneous ventilation, greater acinar dimensions, and lower gas transfer, in addition to lower spirometry, greater airways resistance and reactance, and more air trapping than patients with asthma. Similarly, 129Xe MRI metrics demonstrated greater abnormalities in COPD than asthma when comparing only those with normal forced expiratory volume in 1 s or TLco. Lung function and structure were worse in asthma + COPD than asthma and better than COPD.
CONCLUSIONS: 129Xe MRI alongside PFTs provide phenotypically distinct airway disease signatures to aid diagnosis of asthma and/or COPD. 129Xe MRI is highly sensitive to minimal lung disease and identifies functional/structural phenotypes that may help to guide treatment decisions.
参考来源
- Marshall H, Smith LJ, Biancardi AM, et al. Phenotyping asthma and/or chronic obstructive pulmonary disease using 129Xe MRI and comprehensive physiologic testing. Am J Respir Crit Care Med. 2026. PMID: 41072430. doi:10.1164/rccm.202501-0288OC
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。